Sebo; Peter

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sebo; Peter.The latest application filed is for "mutant cyaa polypeptides and polypeptide derivatives suitable for the delivery of immunogenic molecules into a cell".

Company Profile

0.9.11

Sebo; Peter - Prague CZ
Sebo; Peter - Prague 4 CZ
Sebo; Peter - Praha CZ
Sebo; Peter - Paris FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Mutant CyaA polypeptides and polypeptide derivatives suitable for the delivery of immunogenic molecules into a cell Grant 9,708,596 - Sebo , et al. July 18, 2	2017-07-18
Mutant Cyaa Polypeptides And Polypeptide Derivatives Suitable For The Delivery Of Immunogenic Molecules Into A Cell App 20160083714 - SEBO; PETER ; et al.	2016-03-24
Mutant CyaA polypeptides and polypeptide derivatives suitable for the delivery of immunogenic molecules into a cell Grant 9,222,143 - Sebo , et al. December 29, 2	2015-12-29
Streptavidin And Biotin-based Antigen Delivery System App 20130121958 - Leclerc; Claude ; et al.	2013-05-16
Mutant CyaA Polypeptides and Polypeptide Derivatives Suitable for the Delivery of Immunogenic Molecules Into a Cell App 20120071393 - Sebo; Peter ; et al.	2012-03-22
MUTANT CyaA POLYPEPTIDES AND POLYPEPTIDE DERIVATIVES SUITABLE FOR THE DELIVERY OF IMMUNOGENIC MOLECULES INTO A CELL App 20120052083 - Sebo; Peter ; et al.	2012-03-01
Mutant CyaA polypeptides and polypeptide derivatives suitable for the delivery of immunogenic molecules into a cell Grant 8,017,132 - Sebo , et al. September 13, 2	2011-09-13
Modified Bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof Grant 7,906,123 - Leclerc , et al. March 15, 2	2011-03-15
Nucleic acids encoding protective epitopes of adenyl cyclase-haemolysin (AC-Hly) Grant 7,902,349 - Betsou , et al. March 8, 2	2011-03-08
MUTANT CyaA POLYPEPTIDES AND POLYPEPTIDE DERIVATIVES SUITABLE FOR THE DELIVERY OF IMMUNOGENIC MOLECULES INTO A CELL App 20100239550 - Sebo; Peter ; et al.	2010-09-23
Recombinant adenylate cyclase of BORDETELLA SP. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclase App 20090317854 - Leclerc; Claude ; et al.	2009-12-24
Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections App 20060292161 - Betsou; Fotini ; et al.	2006-12-28
Recombinant adenylate cyclase of Bordetella sp. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclase App 20060286613 - Leclerc; Claude ; et al.	2006-12-21
Modified bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof App 20060159697 - Leclerc; Claude ; et al.	2006-07-20
Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections Grant 6,994,854 - Betsou , et al. February 7, 2	2006-02-07
Recombinant adenylate cyclase of Bordetella sp. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclase App 20060019323 - Leclerc; Claude ; et al.	2006-01-26
Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections Grant 6,309,648 - Betsou , et al. October 30, 2	2001-10-30
Recombinant mutants for inducing specific immune responses Grant 5,679,784 - Ladant , et al. October 21, 1	1997-10-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.